Vision therapy/orthoptics for symptomatic convergence insufficiency in children: Treatment kinetics

Mitchell Scheiman, Marjean Taylor Kulp, Susan Cotter, G. Lynn Mitchell, Michael Gallaway, Mark Boas, Rachel Coulter, Kristine Hopkins, Susanna Tamkins

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose. To evaluate the kinetics of change in symptoms and signs of convergence insufficiency (CI) during 12 weeks of treatment with commonly prescribed vision therapy/orthoptic treatment regimens. Methods. In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic CI were assigned to home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), or office-based placebo therapy with home reinforcement (OBPT). Symptoms and signs were measured after 4, 8, and 12 weeks of treatment. The outcome measures were the mean CI Symptom Survey (CISS), near point of convergence (NPC), positive fusional vergence (PFV), and proportions of patients who were classified as "successful" or "improved" based on a composite measure of CISS, NPC, and PFV. Results. Only the OBVAT group showed significant improvements in symptoms between each visit (p <0.001). Between weeks 8 and 12, all groups showed a significant improvement in symptoms. Between-group differences were apparent by week 8 (p = 0.037) with the fewest symptoms in the OBVAT group. For each group, the greatest improvements in NPC and PFV were achieved during the first 4 weeks. Differences between groups became apparent by week 4 (p <0.001), with the greatest improvements in NPC and PFV in the OBVAT group. Only the OBVAT group continued to show significant improvements in PFV at weeks 8 and 12. The percentage of patients classified as "successful" or "improved" based on our composite measure increased in all groups at each visit. Conclusions. The rate of improvement is more rapid for clinical signs (NPC and PFV) than for symptoms in children undergoing treatment for CI. OBVAT results in a more rapid improvement in symptoms, NPC and PFV, and a greater percentage of patients reaching pre-determined criteria of success when compared with HBPP, HBCVAT+, or OBPT.

Original languageEnglish (US)
Pages (from-to)593-603
Number of pages11
JournalOptometry and Vision Science
Volume87
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Orthoptics
Ocular Motility Disorders
Group Homes
Therapeutics
Signs and Symptoms

Keywords

  • asthenopia
  • computer vergence/accommodative therapy
  • convergence insufficiency
  • exophoria
  • eyestrain
  • orthoptics
  • pencil push-ups
  • placebo therapy
  • school children
  • symptom survey
  • vergence/accommodative therapy
  • vision therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Optometry
  • Medicine(all)

Cite this

Scheiman, M., Kulp, M. T., Cotter, S., Mitchell, G. L., Gallaway, M., Boas, M., ... Tamkins, S. (2010). Vision therapy/orthoptics for symptomatic convergence insufficiency in children: Treatment kinetics. Optometry and Vision Science, 87(8), 593-603. https://doi.org/10.1097/OPX.0b013e3181e61bad

Vision therapy/orthoptics for symptomatic convergence insufficiency in children : Treatment kinetics. / Scheiman, Mitchell; Kulp, Marjean Taylor; Cotter, Susan; Mitchell, G. Lynn; Gallaway, Michael; Boas, Mark; Coulter, Rachel; Hopkins, Kristine; Tamkins, Susanna.

In: Optometry and Vision Science, Vol. 87, No. 8, 08.2010, p. 593-603.

Research output: Contribution to journalArticle

Scheiman, M, Kulp, MT, Cotter, S, Mitchell, GL, Gallaway, M, Boas, M, Coulter, R, Hopkins, K & Tamkins, S 2010, 'Vision therapy/orthoptics for symptomatic convergence insufficiency in children: Treatment kinetics', Optometry and Vision Science, vol. 87, no. 8, pp. 593-603. https://doi.org/10.1097/OPX.0b013e3181e61bad
Scheiman, Mitchell ; Kulp, Marjean Taylor ; Cotter, Susan ; Mitchell, G. Lynn ; Gallaway, Michael ; Boas, Mark ; Coulter, Rachel ; Hopkins, Kristine ; Tamkins, Susanna. / Vision therapy/orthoptics for symptomatic convergence insufficiency in children : Treatment kinetics. In: Optometry and Vision Science. 2010 ; Vol. 87, No. 8. pp. 593-603.
@article{a7d0e593900d4c51a6d3fad456c4b814,
title = "Vision therapy/orthoptics for symptomatic convergence insufficiency in children: Treatment kinetics",
abstract = "Purpose. To evaluate the kinetics of change in symptoms and signs of convergence insufficiency (CI) during 12 weeks of treatment with commonly prescribed vision therapy/orthoptic treatment regimens. Methods. In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic CI were assigned to home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), or office-based placebo therapy with home reinforcement (OBPT). Symptoms and signs were measured after 4, 8, and 12 weeks of treatment. The outcome measures were the mean CI Symptom Survey (CISS), near point of convergence (NPC), positive fusional vergence (PFV), and proportions of patients who were classified as {"}successful{"} or {"}improved{"} based on a composite measure of CISS, NPC, and PFV. Results. Only the OBVAT group showed significant improvements in symptoms between each visit (p <0.001). Between weeks 8 and 12, all groups showed a significant improvement in symptoms. Between-group differences were apparent by week 8 (p = 0.037) with the fewest symptoms in the OBVAT group. For each group, the greatest improvements in NPC and PFV were achieved during the first 4 weeks. Differences between groups became apparent by week 4 (p <0.001), with the greatest improvements in NPC and PFV in the OBVAT group. Only the OBVAT group continued to show significant improvements in PFV at weeks 8 and 12. The percentage of patients classified as {"}successful{"} or {"}improved{"} based on our composite measure increased in all groups at each visit. Conclusions. The rate of improvement is more rapid for clinical signs (NPC and PFV) than for symptoms in children undergoing treatment for CI. OBVAT results in a more rapid improvement in symptoms, NPC and PFV, and a greater percentage of patients reaching pre-determined criteria of success when compared with HBPP, HBCVAT+, or OBPT.",
keywords = "asthenopia, computer vergence/accommodative therapy, convergence insufficiency, exophoria, eyestrain, orthoptics, pencil push-ups, placebo therapy, school children, symptom survey, vergence/accommodative therapy, vision therapy",
author = "Mitchell Scheiman and Kulp, {Marjean Taylor} and Susan Cotter and Mitchell, {G. Lynn} and Michael Gallaway and Mark Boas and Rachel Coulter and Kristine Hopkins and Susanna Tamkins",
year = "2010",
month = "8",
doi = "10.1097/OPX.0b013e3181e61bad",
language = "English (US)",
volume = "87",
pages = "593--603",
journal = "Optometry and Vision Science",
issn = "1040-5488",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Vision therapy/orthoptics for symptomatic convergence insufficiency in children

T2 - Treatment kinetics

AU - Scheiman, Mitchell

AU - Kulp, Marjean Taylor

AU - Cotter, Susan

AU - Mitchell, G. Lynn

AU - Gallaway, Michael

AU - Boas, Mark

AU - Coulter, Rachel

AU - Hopkins, Kristine

AU - Tamkins, Susanna

PY - 2010/8

Y1 - 2010/8

N2 - Purpose. To evaluate the kinetics of change in symptoms and signs of convergence insufficiency (CI) during 12 weeks of treatment with commonly prescribed vision therapy/orthoptic treatment regimens. Methods. In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic CI were assigned to home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), or office-based placebo therapy with home reinforcement (OBPT). Symptoms and signs were measured after 4, 8, and 12 weeks of treatment. The outcome measures were the mean CI Symptom Survey (CISS), near point of convergence (NPC), positive fusional vergence (PFV), and proportions of patients who were classified as "successful" or "improved" based on a composite measure of CISS, NPC, and PFV. Results. Only the OBVAT group showed significant improvements in symptoms between each visit (p <0.001). Between weeks 8 and 12, all groups showed a significant improvement in symptoms. Between-group differences were apparent by week 8 (p = 0.037) with the fewest symptoms in the OBVAT group. For each group, the greatest improvements in NPC and PFV were achieved during the first 4 weeks. Differences between groups became apparent by week 4 (p <0.001), with the greatest improvements in NPC and PFV in the OBVAT group. Only the OBVAT group continued to show significant improvements in PFV at weeks 8 and 12. The percentage of patients classified as "successful" or "improved" based on our composite measure increased in all groups at each visit. Conclusions. The rate of improvement is more rapid for clinical signs (NPC and PFV) than for symptoms in children undergoing treatment for CI. OBVAT results in a more rapid improvement in symptoms, NPC and PFV, and a greater percentage of patients reaching pre-determined criteria of success when compared with HBPP, HBCVAT+, or OBPT.

AB - Purpose. To evaluate the kinetics of change in symptoms and signs of convergence insufficiency (CI) during 12 weeks of treatment with commonly prescribed vision therapy/orthoptic treatment regimens. Methods. In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic CI were assigned to home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), or office-based placebo therapy with home reinforcement (OBPT). Symptoms and signs were measured after 4, 8, and 12 weeks of treatment. The outcome measures were the mean CI Symptom Survey (CISS), near point of convergence (NPC), positive fusional vergence (PFV), and proportions of patients who were classified as "successful" or "improved" based on a composite measure of CISS, NPC, and PFV. Results. Only the OBVAT group showed significant improvements in symptoms between each visit (p <0.001). Between weeks 8 and 12, all groups showed a significant improvement in symptoms. Between-group differences were apparent by week 8 (p = 0.037) with the fewest symptoms in the OBVAT group. For each group, the greatest improvements in NPC and PFV were achieved during the first 4 weeks. Differences between groups became apparent by week 4 (p <0.001), with the greatest improvements in NPC and PFV in the OBVAT group. Only the OBVAT group continued to show significant improvements in PFV at weeks 8 and 12. The percentage of patients classified as "successful" or "improved" based on our composite measure increased in all groups at each visit. Conclusions. The rate of improvement is more rapid for clinical signs (NPC and PFV) than for symptoms in children undergoing treatment for CI. OBVAT results in a more rapid improvement in symptoms, NPC and PFV, and a greater percentage of patients reaching pre-determined criteria of success when compared with HBPP, HBCVAT+, or OBPT.

KW - asthenopia

KW - computer vergence/accommodative therapy

KW - convergence insufficiency

KW - exophoria

KW - eyestrain

KW - orthoptics

KW - pencil push-ups

KW - placebo therapy

KW - school children

KW - symptom survey

KW - vergence/accommodative therapy

KW - vision therapy

UR - http://www.scopus.com/inward/record.url?scp=77955469201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955469201&partnerID=8YFLogxK

U2 - 10.1097/OPX.0b013e3181e61bad

DO - 10.1097/OPX.0b013e3181e61bad

M3 - Article

C2 - 20543758

AN - SCOPUS:77955469201

VL - 87

SP - 593

EP - 603

JO - Optometry and Vision Science

JF - Optometry and Vision Science

SN - 1040-5488

IS - 8

ER -